PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $160.0M | $154.0M | $200.5M | $128.3M | $130.5M |
| Cost of revenue | $114.2M | $116.7M | $147.7M | $79.3M | $71.7M |
| Gross profit | $45.8M | $37.3M | $52.8M | $49.0M | $58.9M |
| Selling, general & administrative | $141.5M | $175.0M | $169.8M | $160.9M | $124.1M |
| Research and development | $97.3M | $134.9M | $187.2M | $193.0M | $112.9M |
| Operating expenses | $599.6M | $511.6M | $387.2M | $356.2M | $269.3M |
| Operating income | -$553.9M | -$474.3M | -$334.5M | -$307.2M | -$210.4M |
| Interest expense | $7.0M | $13.4M | $14.3M | $14.7M | $12.5M |
| Pretax income | -$546.1M | -$309.5M | -$318.2M | -$314.2M | -$274.9M |
| Income tax expense | $318,000 | $316,000 | -$11.4M | $0 | -$93.6M |
| Net income | -$546.4M | -$309.9M | -$306.7M | -$314.2M | -$181.2M |
| Balance Sheet | |||||
| Cash and equivalents | $63.7M | $55.4M | $179.9M | $325.1M | $460.7M |
| Current assets | $375.1M | $495.7M | $742.0M | $852.1M | $1.1B |
| Total assets | $784.1M | $1.3B | $1.7B | $1.8B | $2.0B |
| Current liabilities | $72.8M | $66.3M | $95.0M | $263.3M | $71.7M |
| Total liabilities | $778.7M | $753.9M | $1.0B | $1.2B | $1.2B |
| Total debt | — | — | — | $900.0M | $900.0M |
| Stockholders' equity | $5.3M | $506.6M | $701.3M | $562.9M | $791.0M |
| Cash Flow Statement | |||||
| Cash from operations | -$111.2M | -$206.1M | -$259.2M | -$263.2M | -$111.2M |
| Depreciation and amortization | $13.0M | $13.8M | $11.5M | $9.5M | $7.2M |
| Stock-based compensation | $41.7M | $71.0M | $72.1M | $78.6M | $73.4M |
| Capital expenditure | $2.7M | $6.2M | $8.8M | $16.8M | $5.9M |
| Free cash flow | -$113.9M | -$212.2M | -$268.0M | -$280.0M | -$117.1M |
| Impairments | — | $144.5M | — | — | — |
Shares outstanding 310.6M · Free float 88.1%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.